(Q39425615)

11 September 2017

Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group (English)

1 reference

11 September 2017

1 reference

J Heywood

1

1 reference

11 September 2017

M A Bomhof

2

1 reference

11 September 2017

A Pradalier

3

1 reference

11 September 2017

L Thaventhiran

4

1 reference

11 September 2017

P Winter

5

1 reference

11 September 2017

H Hassani

6

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

11 September 2017

1 reference

11 September 2017

20

1 reference

11 September 2017

5

1 reference

11 September 2017

470-474

1 reference

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

11 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.00066.X

Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.00066.X

Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.00066.X

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.00066.X

10.1046/J.1468-2982.2000.00066.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference